Cargando…

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial

PURPOSE: The AVAglio trial reported a significant survival benefit for first line bevacizumab treatment in patients with IDH wildtype glioblastoma of the proneural gene expression subtype. We here aim to replicate these findings in an independent trial cohort. METHODS: We evaluate the treatment bene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Johannes, Zeyen, Thomas, Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Hau, Peter, Seidel, Clemens, Goldbrunner, Roland, Tabatabai, Ghazaleh, Vatter, Hartmut, Tzaridis, Theophilos, Schneider, Matthias, Herrlinger, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589156/ https://www.ncbi.nlm.nih.gov/pubmed/37787906 http://dx.doi.org/10.1007/s11060-023-04470-9

Ejemplares similares

Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
por: Weller, Johannes, et al.
Publicado: (2022)

Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
por: Weller, J., et al.
Publicado: (2023)

Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
por: Schneider, Matthias, et al.
Publicado: (2020)

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial
por: Zeyen, Thomas, et al.
Publicado: (2022)

Distress in Neuro-Oncology Patients and Its Implications for Communication
por: Roos, Carolin, et al.
Publicado: (2023)

Postoperative Prolonged Mechanical Ventilation in Patients With Newly Diagnosed Glioblastoma—An Unrecognized Prognostic Factor
por: Schuss, Patrick, et al.
Publicado: (2020)

Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature
por: Tzaridis, Theophilos, et al.
Publicado: (2020)

Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma
por: Schneider, Matthias, et al.
Publicado: (2021)

Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma — forfeiture of surgically achieved advantages?
por: Lehmann, Felix, et al.
Publicado: (2023)

Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma
por: Schneider, Matthias, et al.
Publicado: (2021)

Survival in patients with surgically treated brain metastases: does infratentorial location matter?
por: Hamed, Motaz, et al.
Publicado: (2023)

Outcome of Tumor-Associated Proptosis in Patients With Spheno-Orbital Meningioma: Single-Center Experience and Systematic Review of the Literature
por: Schneider, Matthias, et al.
Publicado: (2020)

Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasis
por: Schweppe, Justus August, et al.
Publicado: (2023)

Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates
por: Schneider, Matthias, et al.
Publicado: (2020)

Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2020)

The Impact of Prolonged Mechanical Ventilation on Overall Survival in Patients With Surgically Treated Brain Metastases
por: Schuss, Patrick, et al.
Publicado: (2021)

Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2021)

Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
por: Bahna, Majd, et al.
Publicado: (2021)

Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection
por: Borger, Valeri, et al.
Publicado: (2021)

Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease
por: Potthoff, Anna-Laura, et al.
Publicado: (2023)

Preoperative Metastatic Brain Tumor-Associated Intracerebral Hemorrhage Is Associated With Dismal Prognosis
por: Hamed, Motaz, et al.
Publicado: (2021)

ACKT: A Proposal for a Novel Score to Predict Prolonged Mechanical Ventilation after Surgical Treatment of Meningioma in Geriatric Patients
por: Scharnböck, Elisa, et al.
Publicado: (2020)

The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival
por: Schneider, Matthias, et al.
Publicado: (2021)

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
por: Seliger, Corinna, et al.
Publicado: (2022)

Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)
por: Ilic, Inja, et al.
Publicado: (2022)

Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma
por: Müller, Andreas, et al.
Publicado: (2016)

Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System
por: Maiseyeu, Ivan, et al.
Publicado: (2022)

Postoperative prolonged mechanical ventilation correlates to poor survival in patients with surgically treated spinal metastasis
por: Hamed, Motaz, et al.
Publicado: (2022)

Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
por: Seliger, Corinna, et al.
Publicado: (2023)

Outcome of Elderly Patients With Surgically Treated Brain Metastases
por: Heimann, Muriel, et al.
Publicado: (2021)

Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
por: Burger, Michael C., et al.
Publicado: (2017)

Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic Applications
por: Tzaridis, Theophilos, et al.
Publicado: (2021)

Transcriptional control of vertebrate neurogenesis by the proneural factor Ascl1
por: Vasconcelos, Francisca F., et al.
Publicado: (2014)

ME2 Promotes Proneural–Mesenchymal Transition and Lipogenesis in Glioblastoma
por: Yang, Mengting, et al.
Publicado: (2021)

Dehydration Status at Admission Predicts Recurrence in Patients with Traumatic Chronic Subdural Hematoma
por: Mainka, Niklas, et al.
Publicado: (2022)

Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ivq9s9bt7kqa6s4ahnprvlfut